美股市场个股详情
GERNW GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)
- 1.400
- 0.0000.00%
延时15分钟行情收盘价 12/26 16:00 (美东)
0总市值0.00市盈率TTM
0.000最高价0.000最低价0股成交量0.000今开1.400昨收0.00成交额0.00%换手率0.00市盈率(静)0总股本2.14052周最高0.00市净率0流通值0.72552周最低--股息TTM0流通股2.140历史最高--股息率TTM0.00%振幅0.725历史最低--平均价1股每手
关于GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)公司
杰龙公司是一家临床阶段生物制药公司，专注于研究和开发癌症治疗药物。公司的在研药物 Imelstat 正在接受测试，用于治疗骨髓增生异常综合征，一种血液疾病，和骨髓纤维化，一种影响骨髓的罕见血癌。公司通过合作协议，里程碑，版税和许可安排获得收入。杰龙拥有该药物的各种权利。该公司的业务只有一个分部，即开发肿瘤治疗产品。
公司介绍
公司代码GERNW
公司名称GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)
上市日期1996/07/30
成立日期1990
CEODr. John A. Scarlett,M.D.
所属市场粉单
员工数量141
年结日12-31
公司地址919 East Hillsdale Boulevard,Suite 250
城市Foster City
省份加利福尼亚州
国家美国
邮编94404
电话1-650-473-7700
董事高管
- 姓名
- 职务
- 年薪
- Dr. John A. Scarlett,M.D.
- Chairman of the Board, Chief Executive Officer and President
- 492.41万
- Scott A. Samuels
- Executive Vice President, Chief Legal Officer and Corporate Secretary
- 360.87万
- Dr. Faye Feller
- Executive Vice President and Chief Medical Officer
- --
- Michelle Robertson
- Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
- 246.97万
- Edward E. Koval
- Executive Vice President and Chief Business Officer
- --
- Melissa A. Kelly Behrs
- Executive Vice President, Business Operations and Chief Alliance Officer
- --
- Dr. Andrew J. Grethlein,PhD
- Executive Vice President and Chief Operating Officer
- 241.51万
- Shannon T. Odam
- Senior Vice President and Chief People Officer
- --
- Anil Kapur
- Executive Vice President, Corporate Strategy and Chief Commercial Officer
- --
- Dr. Susan M. Molineaux, PhD
- Independent Director
- 34.59万
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Independent Director
- 35.09万
- Elizabeth G. O’Farrell
- Lead Independent Director
- 37.55万
- Dawn Carter Bir
- Independent Director
- 34.31万
- John F. McDonald
- Independent Director
- 34.84万
- Dr. V. Bryan Lawlis, PhD
- Independent Director
- 36.09万
- Dr. Gaurav Aggarwal, M.D.
- Independent Director
- 29.08万
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据